Though Merck's study showed that cladribine reduced the relapse rate, Dunster said the real question was whether the drug slowed the disease's progression.
虽然默克研究显示克拉屈滨会降低复发率，邓斯特称真正的问题是该药是否会减缓该疾病的进程。
Though Merck's study showed that cladribine reduced the relapse rate, Dunster said the real question was whether the drug slowed the disease's progression.
虽然默克研究显示克拉屈滨会降低复发率，邓斯特称真正的问题是该药是否会减缓该疾病的进程。
应用推荐